Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cong (Ava) Fan"'
Autor:
J. Lin, M. Dandulakis, P. Smith, Cong (Ava) Fan, L. Xu, Jocelyn Reader, Teklu Legesse, Mark S. Carey, Dana M. Roque, Gautam G. Rao, Amy M. Fulton
Publikováno v:
Gynecologic Oncology. 159:122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db39acec586548be1c62ba0b7e3bf07
https://doi.org/10.1016/j.ygyno.2020.05.144
https://doi.org/10.1016/j.ygyno.2020.05.144
Autor:
Gautam G. Rao, Ningbo Jian, Jocelyn Reader, Olga Goloubeva, Sulan Wu, Teklu Legesse, Dana M. Roque, Amy M. Fulton, Paul N. Staats, Mark S. Carey, Cong (Ava) Fan, McMillan Ching
Publikováno v:
Clinical Cancer Research. 26:B67-B67
Ovarian cancer has the highest mortality incidence of all gynecologic malignancies in the United States. The majority of ovarian cancer cases lead to recurrent disease that is often incurable and fatal due to innate or acquired chemoresistance; there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3671ec72e9afe4e9f04c8cc227f722a7
https://doi.org/10.1158/1557-3265.ovca19-b67
https://doi.org/10.1158/1557-3265.ovca19-b67
Autor:
Trevor J. Mathias, Sulan Wu, Cong (Ava) Fan, Julia A. Ju, Rachel M. Lee, Jocelyn Reader, McMillan Ching, Christopher M. Jewell, Mark S. Carey, Michele Vitolo, Dana M. Roque, Eleanor C Ory, Cornell J. Lee, Amy M. Fulton, Gautam G. Rao, Stuart S. Martin
Publikováno v:
Clinical Cancer Research. 26:B68-B68
Ovarian carcinomas are categorized into five major histotypes, each characterized by distinct differences in grade at diagnosis, presentation with metastatic disease, and clinical responses to treatments. Microtentacles (McTNs), microtubule-based ext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38c919027301c6847b077a24b9a23910
https://doi.org/10.1158/1557-3265.ovca19-b68
https://doi.org/10.1158/1557-3265.ovca19-b68
Publikováno v:
Current Treatment Options in Oncology. 19
The rise of immunotherapy is the greatest advance in oncology to occur over the last several years, but applications in gynecologic malignancies lag behind other tumors. The term "immunotherapy" envelops monoclonal antibodies as receptor mediators, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76104769f1aac168a9c1f7fd8fe832d7
https://doi.org/10.1007/s11864-018-0584-3
https://doi.org/10.1007/s11864-018-0584-3
Publikováno v:
Gynecologic Oncology. 154:71-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602abc09806e1806339b8b3042888cf1
https://doi.org/10.1016/j.ygyno.2019.04.169
https://doi.org/10.1016/j.ygyno.2019.04.169
Autor:
Gautam G. Rao, Paul N. Staats, Amy M. Fulton, Dana M. Roque, Cong (Ava) Fan, Mc Millan Ching, Jocelyn Reader
Publikováno v:
Clinical Cancer Research. 24:A50-A50
Advanced ovarian clear cell carcinoma (OCCC) is associated with a survival disadvantage relative to ovarian serous carcinoma following platinum/taxane-based chemotherapy and optimal cytoreduction. Prostaglandin E2 (PGE2) contributes to disease progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac39816721e2465126c9b6e6bed3e2fb
https://doi.org/10.1158/1557-3265.ovca17-a50
https://doi.org/10.1158/1557-3265.ovca17-a50
Autor:
Mc Millan Ching, Paul N. Staats, Jocelyn Reader, Dana M. Roque, Cong (Ava) Fan, Gautam G. Rao, Amy M. Fulton
Publikováno v:
Clinical Cancer Research. 24:A22-A22
Ovarian cancer is the leading cause of death from gynecologic malignancy in the United States. Most cases of ovarian cancer present in late stages, leading to recurrent disease that is incurable and often fatal due to innate or acquired chemoresistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fc04e70809249b2707dee9d9d3d8976
https://doi.org/10.1158/1557-3265.ovca17-a22
https://doi.org/10.1158/1557-3265.ovca17-a22